• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ocugen Inc.

Headquarters: Malvern, PA, United States
Website: http://ocugen.com
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: Shankar Musunuri, PhD, MBA
Number Of Employees: 95
Enterprise Value: $192,140,072
PE Ratio: -3.82
Exchange/Ticker 1: NASDAQ:OCGN
Exchange/Ticker 2: N/A
Latest Market Cap: $201,324,096

BioCentury | Mar 19, 2024
Management Tracks

Arvinas hires Berkowitz as CMO

Plus: BoA veteran Setia joins MapLight as CFO, and updates from Ocugen, Clearside, Telum, SmartCella, AstriVax and Solu
Read More
BioCentury | Mar 7, 2023
Management Tracks

Seven Amarin directors resign after Sarissa proxy win

Plus: Ocugen expands Quan Vu’s role to CBO and CFO, and updates from BPGbio and MediWound
Read More
BioCentury | Feb 3, 2023
Management Tracks

Vessey to leave BMS in July

Plus: Nichols joining enGene as CEO and updates from Invivyd, Exai and more
Read More
BioCentury | May 24, 2022
Product Development

May 23 Quick Takes: priority review for ImmunoGen’s ovarian cancer ADC

Plus Concert meets in Phase III and updates from Sino, Centaurus, Ocugen and more
Read More
BioCentury | Apr 13, 2022
Product Development

April 12 Quick Takes: FDA lifts clinical hold on magrolimab studies

Plus: Setback for Myovant at FDA and updates from Takeda, Ocugen, Prilenia, AbbVie and more
Read More
BioCentury | Mar 23, 2022
Management Tracks

Sandrock becomes CEO at Voyager 

Plus Faga replaces Suria as Anaptys CEO and updates from Mozart, Longboard, Capsida, Phathom and more
Read More
BioCentury | Mar 9, 2022
Management Tracks

Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO

Plus updates from Centessa, Teon, AnchorDx, Pillar and more
Read More
BioCentury | Mar 5, 2022
Regulation

March 4 Quick Takes: FDA rebuffs Ocugen’s Covaxin pediatric EUA

Plus Arcus’ take on WuXi Biologics fallout and updates from Shionogi, Huayi Lejian
Read More
BioCentury | Jan 25, 2022
Management Tracks

Braunstein now CMO at Idorsia

Plus Kush, Haddach join RayzeBio and updates from Coherus, InterVenn, AsherBio and more
Read More
BioCentury | Nov 6, 2021
Deals

Nov. 5 Quick Takes: $103M raise to support bit.bio’s cell coding tech

Plus Alphabet launches digital biology venture, IO Biotech’s IPO, setbacks for Deciphera, Calithera and more 
Read More
Items per page:
1 - 10 of 25
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa